lymphoma

(redirected from thymic lymphoma)
Also found in: Thesaurus, Medical, Encyclopedia.

lym·pho·ma

 (lĭm-fō′mə)
n. pl. lym·pho·ma·ta (-mə-tə) or lym·pho·mas
1. Any of various malignant tumors that arise from the lymphocytic cells of the immune system.
2. Any of various cancers characterized by the development of such tumors, especially Hodgkin lymphoma and non-Hodgkin lymphoma.

lym·pho′ma·toid′, lym·pho′ma·tous (-təs) adj.

lymphoma

(lɪmˈfəʊmə)
n, pl -mata (-mətə) or -mas
(Pathology) any form of cancer of the lymph nodes. Also called: lymphosarcoma
lymˈphomatous, lymˈphomaˌtoid adj

lym•pho•ma

(lɪmˈfoʊ mə)

n., pl. -mas, -ma•ta (-mə tə)
a tumor arising from any of the cellular elements of lymph nodes.
[1870–75]
lym•pho′ma•toid`, adj.

lymphoma

a growth of lymphoid tissue that is commonly cancerous and typically enlarges the lymph nodes.
See also: Cancer
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.lymphoma - a neoplasm of lymph tissue that is usually malignant; one of the four major types of cancer
cancer, malignant neoplastic disease - any malignant growth or tumor caused by abnormal and uncontrolled cell division; it may spread to other parts of the body through the lymphatic system or the blood stream
Hodgkin's disease - a malignant disorder in which there is progressive (but painless) enlargement of lymph tissue followed by enlargement of the spleen and liver
Translations
lymfom

lym·pho·ma

n. linfoma, neoplasma del tejido linfático.

lymphoma

n linfoma m; B cell — linfoma de células B; Hodgkin’s — linfoma (de) Hodgkin; mucosa-associated lymphoid tissue (MALT) — linfoma MALT, linfoma de tejido linfoide asociado a mucosas; non-Hodgkin’s — linfoma no Hodgkin; T cell — linfoma de células T
References in periodicals archive ?
Results of necropsy and histopathologic evaluation identified the mass as thymic lymphoma with proventricular metastasis.
In thymic rebound hyperplasia, the thymic enlargement is usually symmetrical, and the contour is smooth and nonlobulated and conforms to the shape of neighbouring structures; while in recurrent thymic lymphoma, the patient is symptomatic, and the thymus is generally asymmetric and nodular and shows heterogeneous signal intensity on MRI.
Bcl11b is a tumor suppressor and loss of a Bcl11b allele contributes to thymic lymphoma development.
Thymoma, lymphoma, and germ cell neoplasms can all have a similar appearance either as a well-defined lobular mass (thymoma and thymic lymphoma) or heterogeneous attenuation and calcification (thymoma and germ cell neoplasm).
Immunhistochemical testing can be helpful to differentiate between thymoma and thymic lymphoma by labeling cytokeratins CK14 and CK18, as well as showing positive results for proliferating cell nuclear antigen in cases of thymomas.
Abstract: A 4-year-old Java sparrow (Lonchura oryzivora) was diagnosed with thymic lymphoma based on the results of histopathologic evaluation and immunohistochemical staining of a Tru-cut biopsy sample.
The FDA decision was based, in part, on evidence from studies conducted by NIEHS and NTP scientists with the p53(+/-) mouse, which demonstrated that phenolphthalein induced thymic lymphomas accompanied by a loss of the p53 wild-type allele, within just 4 months (Dunnick et al.